PlexusDx precision-wellness approach considers genetic and biomarker factors that influence GI tolerance and microbiome health alongside peptide therapy
2-Acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylcarbonylamino)- phenylcarbamoylsulfanyl]propionic acid and its derivatives as a novel class of glutathione reductase inhibitors
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a portion of a naturally occurring protein found in gastric juice
Fontana, J., Kucera, O., Mezera, V., Andel, M
Strilakou AA, Lazaris AC, Perelas AI, et al
The SELECT trial demonstrated cardiovascular benefits of semaglutide independent of weight loss, leading to a cardiovascular risk reduction indication that does not require a specific BMI